Per Hansen

Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity.

J. Kopecký, K. Pacak, J. Ženka, 2019, Seminars in oncology.

Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations

J. Kopecký, K. Pacak, J. Ženka, 2021, Cancer Immunology, Immunotherapy.

The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma.

K. Pacak, J. Ženka, J. Chmelař, 2023, International immunopharmacology.